Highlights Artrya Limited

Equities

AYA

AU0000182412

Delayed Australian S.E. Other stock markets 01:35:04 07/06/2024 BST			5-day change	1st Jan Change
0.25 ^AUD	0.00%		-5.66%	+4.17%

03:21am	Artrya Submits Second Q-Submission to Finalize FDA Application	MT
04-02	Artrya Signs Commercial Agreement for Heart Disease Diagnostic Technology; Shares Up 8%	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Artrya Submits Second Q-Submission to Finalize FDA Application	02:21am	MT
Artrya Signs Commercial Agreement for Heart Disease Diagnostic Technology; Shares Up 8%	04-02	MT
Artrya Gears Up for US Launch After Tanner Health System Partnership	03-12	MT
Artrya Limited Reports Earnings Results for the Six Months Ended December 31, 2023	02-28	CI
Artrya Enters US Market Via Strategic Commercial Partnership	11-20	MT
Artrya Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31/08/23	CI
Artrya Completes Key Step for US Regulatory Approval of Coronary Artery Software	03/05/23	MT
Artrya Limited Reports Earnings Results for the Half Year Ended December 31, 2022	21/02/23	CI
Artrya Obtains UK Regulatory Approval for Salix Coronary Anatomy Product	07/11/22	MT
Artrya Limited Gains UK Regulatory Approval for its Salix Coronary Anatomy Product	07/11/22	CI
Artrya Secures EU Approval for Coronary Analysis Product	28/10/22	MT
Artrya Limited Receives Regulatory Approval for Its Salix Coronary Anatomy Product in Europe	27/10/22	CI
Artrya Limited Reports Earnings Results for the Full Year Ended June 30, 2022	31/08/22	CI
Artrya Limited Receives Advice That Based on the Initial 510(K) Application, Clearance	16/06/22	CI
Artrya Signs Clinical Partnership with US Hospital for Cardiac Analysis Software	09/05/22	MT
Artrya Limited Signs First U.S. Hospital Clinical Partnership with Heart Center Inc	08/05/22	CI
Artrya Changes Registered Office Address	19/04/22	MT
Artrya Establishes US Operations	29/03/22	MT
Artrya Limited Announces the Formation of the Company's American Subsidiary, Artrya USA Inc	28/03/22	CI
Artrya : Half Year Financial Report Presentation	21/02/22	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Artrya Limited

Equities

AYA

AU0000182412

Highlights

Filters